Navegar

Colección

Datos Estadísticas

Artículo

De Catabbi, S.B.; De Calmanovici, R.W.; Minutolo, C.; Aldonatti, C.; De Viale, L.C.S.M. "Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme" (1999) Biochemistry and Molecular Biology International. 47(6):945-956
Estamos trabajando para incorporar este artículo al repositorio
Consulte la política de Acceso Abierto del editor

Abstract:

Porphyrinogen carboxy-lyase is an enzyme that sequentially decarboxylates uroporphyrinogen III (8-COOH) to yield coproporphyrinogen III (4-COOH). In mammals this enzyme activity is impaired by hexachlorobenzene treatment, through generation of an enzyme inhibitor. The interaction of porphyrinogen carboxy-lyase inhibitor, extracted from the liver of hexachlorobenzene-treated rats, with substrate decarboxylation sites on the enzyme, was studied using four different carboxylated substrates belonging to the isomeric III series of naturally-formed porphyrinogens containing 8-, 7-, 6- and 5-COOH. Similar inhibitor effects were elicited against all the substrates assayed, with the exception of pentacarboxyporphyrinogen III in which decarboxylation was not inhibited to same extent. Enzyme protection assays in the presence of the different substrates, indicated that each porphyrinogen protects its own decarboxylation from inhibitor action. Preincubation of the inhibitor with normal enzyme increased its inhibitory effect. On the other hand, preincubation of both enzyme and inhibitor with superoxide dismutase or mannitol, did not alter inhibitory activity. Preincubation of the inhibitor with a number showed that only arginine and its derivative Nα-Benzoyl-L-Arginine interact with the inhibitor, noticeably reducing its ability to inhibit porphyrinogen carboxy-lyase. Albumin, histidine, serine, cysteine and imidazol, were unable to quench inhibitor activity. The present results indicate that the inhibitor acts at the binding site of each porphyrinogen. Taking into account that arginine is related to enzyme activity, and that histidine is found at the binding site of the substrates, the results suggest that the inhibitor could bind to arginine residues, blocking the access of substrates to histidine and altering the adequate orientation for decarboxylation by masking the positively charged active site necessary for porphyrinogen binding to the enzyme. In addition an indirect effect of the inhibitor mediated through free radicals could be discarded.

Registro:

Documento: Artículo
Título:Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme
Autor:De Catabbi, S.B.; De Calmanovici, R.W.; Minutolo, C.; Aldonatti, C.; De Viale, L.C.S.M.
Filiación:Depto. de Quim. Biológica, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Nuñez 1428, Buenos Aires, Argentina
Capital Federal (1429), O'Higgins 4332, Buenos Aires, Argentina
Palabras clave:Hexachlorobenzene; Porphyria; Porphyrinogens; Porphyrins; Uroporphyrinogen; Uroporphyrinogen decarboxylase inhibitor; hexachlorobenzene; liver enzyme; porphyrinogen; uroporphyrinogen decarboxylase; animal experiment; animal tissue; article; decarboxylation; enzyme active site; female; liver; nonhuman; porphyria; rat; Animals; Arginine; Binding Sites; Carboxy-Lyases; Enzyme Inhibitors; Female; Hexachlorobenzene; Humans; Liver; Porphyrias; Porphyrinogens; Rats; Rats, Wistar; Uroporphyrinogens; Animalia; Mammalia
Año:1999
Volumen:47
Número:6
Página de inicio:945
Página de fin:956
Título revista:Biochemistry and Molecular Biology International
Título revista abreviado:Biochem. Mol. Biol. Int.
ISSN:10399712
CODEN:BMBIE
CAS:Arginine, 74-79-3; benzoylarginine ethyl ester, 971-21-1; Carboxy-Lyases, EC 4.1.1.-; Enzyme Inhibitors; Hexachlorobenzene, 118-74-1; porphyrinogen carboxy-lyase, EC 4.1.1.-; Porphyrinogens; Uroporphyrinogens
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10399712_v47_n6_p945_DeCatabbi

Referencias:

  • Mauzerall, A., Granick, S., (1958) J. Biol. Chem., 232, pp. 1141-1162
  • Del C Batlle, A.M., Grinstein, M., (1962) Biochim. Biophys. Acta, 62, pp. 197-200
  • San Martin De Viale, L.C., Grinstein, M., (1968) Biochim. Biophys. Acta, 158, pp. 79-91
  • Elder, G.H., Evans, J.O., Matlin, S.A., (1976) Clin. Sci. Molec. Med., 51, pp. 71-80
  • San Martin De Viale, L.C., Rios De Molina, M.C., Wainstok De Calmanovicci, R., Tomio, J.M., (1977) Biochem. J., 168, pp. 393-400
  • Wainstok De Calmanovici, R., Rios De Molina Del C, M., Taira De Yamasato, M.C., Tomio, J.M., San Martin De Viale, L.C., (1984) Biochem. J., 218, pp. 753-763
  • Tomio, J.M., Garcia, R.C., San Martin De Viale, L.C., Grinstein, M., (1970) Biochim. Biophys. Acta, 198, pp. 353-363
  • De Verneuil, H., Grandchamp, B., Norman, Y., (1980) Biochim. Biophys.Acta, 611, pp. 174-186
  • Staka, J.G., Kushner, J.P., (1983) Biochemistry, 22, pp. 4664-4672
  • Billi De Catabbi, S.C., Del C Rios De Molina, M., San Martin De Viale, L.C., (1991) Int. J. Biochem., 23, pp. 675-679
  • Billi De Catabbi, S.C., San Martin De Viale, L.C., (1994) Int. J. Biochem., 26, pp. 595-600
  • Del C Rios De Molina, M., Wainstok De Calmanovici, R., San Martin De Viale, L.C., (1980) Int. J. Biochem., 12, pp. 1027-1032
  • Cantoni, L., Dal Fiume, D., Ruggieri, R., (1984) Int. J. Biochem., 16, pp. 561-565
  • Smith, A.G., Francis, J.E., (1987) Biochem. J., 246, pp. 221-226
  • Billi, S.C., Wainstok De Calmanovici, R., San Martin De Viale, L.C., (1986) Proceedings of an International Symposium, , Morris, C.R. and Cabrai, J.R.P. eds. I.A.R.C. Scientific Publications No.77,487-491,International Agency for Research on Cancer, Lyon
  • Francis, J.E., Smith, A.G., (1988) FEBS Lett., 233, pp. 311-314
  • De Matteis, F., Harvey, C., Reed, C., Hempenius, R., (1988) Biochem. J., 250, pp. 161-169
  • Lambrecht, R.W., Jacobs, J.M., Sinclair, P.R., Sinclair, J.F., (1990) Biochem. J., 269, pp. 437-441
  • Guo, R., Lim, C.K., De Matteis, F., (1996) Biomed Chromatography, 10, pp. 213-220
  • San Martin De Viale, L.C., Viale, A.A., Nacht, S., Grinstein, M., (1970) Clin Chim. Acta., 28, pp. 13-23
  • Del C Rios De Molina, M., Wainstok De Calmanovici, R., San Martin De Viale, L.C., (1987) Int J. Biochem., 19, pp. 365-372

Citas:

---------- APA ----------
De Catabbi, S.B., De Calmanovici, R.W., Minutolo, C., Aldonatti, C. & De Viale, L.C.S.M. (1999) . Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme. Biochemistry and Molecular Biology International, 47(6), 945-956.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10399712_v47_n6_p945_DeCatabbi [ ]
---------- CHICAGO ----------
De Catabbi, S.B., De Calmanovici, R.W., Minutolo, C., Aldonatti, C., De Viale, L.C.S.M. "Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme" . Biochemistry and Molecular Biology International 47, no. 6 (1999) : 945-956.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10399712_v47_n6_p945_DeCatabbi [ ]
---------- MLA ----------
De Catabbi, S.B., De Calmanovici, R.W., Minutolo, C., Aldonatti, C., De Viale, L.C.S.M. "Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme" . Biochemistry and Molecular Biology International, vol. 47, no. 6, 1999, pp. 945-956.
Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10399712_v47_n6_p945_DeCatabbi [ ]
---------- VANCOUVER ----------
De Catabbi, S.B., De Calmanovici, R.W., Minutolo, C., Aldonatti, C., De Viale, L.C.S.M. Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme. Biochem. Mol. Biol. Int. 1999;47(6):945-956.
Available from: https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_10399712_v47_n6_p945_DeCatabbi [ ]